The Criteria of Interim Therapy Change for Patients With Diffuse Large B-Cell Lymphoma: Interim Δspd Less Than 80% vs. 50%

Hematological Oncology - United Kingdom
doi 10.1002/hon.91_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search